New patent for Gilead Sciences drug VOSEVI

   April 14, 2024    Comments Off on New patent for Gilead Sciences drug VOSEVI    Posted in: Patent Added

Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nineteen…
Source

Continue reading

New patent for Strongbridge drug RECORLEV

   April 14, 2024    Comments Off on New patent for Strongbridge drug RECORLEV    Posted in: Patent Added

Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source

Continue reading
Biotechblog